No Matches Found
No Matches Found
No Matches Found
Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
Hemo Organic Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 28 April 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score has declined to 23.0, signalling heightened risk for investors amid sideways technical trends and flat financial performance.
Hemo Organic Ltd Upgraded to Sell as Technicals Improve Amidst Mixed Fundamentals
Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 21 Apr 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain under pressure. Investors should weigh the mildly bullish technical signals against the company’s persistent operational challenges and valuation concerns.
Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 Apr 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and challenging valuation metrics, signalling heightened risk for investors amid a volatile market backdrop.
Hemo Organic Ltd Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals
Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges, prompting a reassessment of its risk and return profile by analysts.
Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 April 2026. This revision reflects a combination of deteriorating technical indicators, flat financial performance, and weak fundamental metrics, signalling heightened risk for investors amid challenging market conditions.
Are Hemo Organic Ltd latest results good or bad?
Hemo Organic Ltd's latest results are concerning, showing zero revenue for the second consecutive quarter and a net loss of ₹0.03 crores, indicating significant operational challenges and financial distress. The company's inconsistent performance and negative balance sheet raise doubts about its sustainability and future prospects.
When is the next results date for Hemo Organic Ltd?
The next results date for Hemo Organic Ltd is 13 February 2026.
Hemo Organic Ltd is Rated Sell
Hemo Organic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the latest insights into the company's performance and outlook.
Hemo Organic Hits New 52-Week High at Rs.22.51 Marking Strong Momentum
Hemo Organic, a key player in the Trading & Distributors sector, has reached a significant milestone by touching a new 52-week high of Rs.22.51. This achievement reflects a sustained upward momentum, with the stock demonstrating robust performance over the past week and outperforming its sector peers.
Hemo Organic Hits New 52-Week High of Rs.21.44, Marking Strong Momentum
Hemo Organic, a key player in the Trading & Distributors sector, reached a fresh 52-week high of Rs.21.44 today, reflecting a sustained rally that has captured market attention. The stock’s performance over recent sessions highlights notable momentum within a challenging broader market environment.
Hemo Organic Hits New 52-Week High of Rs.20.42 Marking Significant Milestone
Hemo Organic, a key player in the Trading & Distributors sector, reached a new 52-week high today, touching Rs.20.42. This milestone reflects a sustained upward momentum, with the stock outperforming its sector and demonstrating robust price strength over recent sessions.
Hemo Organic Hits New 52-Week High of Rs.19.45, Marking Significant Rally
Hemo Organic, a key player in the Trading & Distributors sector, has reached a new 52-week high of Rs.19.45, reflecting a notable surge in its stock price. This milestone underscores the stock’s strong momentum over recent sessions amid broader market fluctuations.
Hemo Organic Hits New 52-Week High at Rs.18.53 Marking Significant Milestone
Hemo Organic, a key player in the Trading & Distributors sector, reached a fresh 52-week high of Rs.18.53 today, underscoring a notable phase of momentum for the stock amid a mixed market environment.
Hemo Organic Hits New 52-Week High of Rs.17.65, Marking Significant Market Momentum
Hemo Organic, a key player in the Trading & Distributors sector, reached a fresh 52-week high of Rs.17.65 today, reflecting notable momentum in its stock performance amid a broadly positive market environment.
Hemo Organic Hits New 52-Week High at Rs.15.25 Mark
Hemo Organic, a key player in the Trading & Distributors sector, reached a significant milestone today by touching a new 52-week high of Rs.15.25. This achievement underscores the stock’s strong momentum amid a mixed market environment.
Hemo Organic Hits New 52-Week High at Rs.14.53 Mark
Hemo Organic, a player in the Trading & Distributors sector, has reached a significant milestone by touching a new 52-week high of Rs.14.53 today, reflecting sustained momentum over the past week and notable outperformance relative to its sector peers.
Hemo Organic Surges with Unprecedented Buying Interest, Hits New 52-Week High
Hemo Organic Ltd has witnessed extraordinary buying momentum, registering a 4.99% gain today and hitting a fresh 52-week high of Rs.14.53. The stock’s performance starkly contrasts with the broader market, as the Sensex edged up by a mere 0.08%, underscoring the intense demand and absence of sellers in the queue.
Hemo Organic Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Hemo Organic, a player in the Trading & Distributors sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical momentum and fundamental challenges. While recent technical indicators suggest a more optimistic trend, the company’s financial performance and valuation metrics present a nuanced picture for investors.
How has been the historical performance of Hemo Organic?
Hemo Organic has shown significant financial improvement from March 2024 to March 2025, with net sales rising from 0.02 Cr to 2.41 Cr and a turnaround in profitability, achieving a profit after tax of 0.16 Cr. However, the company faces challenges with increased total liabilities, which rose to 4.70 Cr.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
